US Stock MarketDetailed Quotes
DXCM DexCom
- 137.870
- +3.870+2.89%
Close Apr 24 16:00 ET
- 137.920
- +0.050+0.04%
Pre 08:33 ET
54.60BMarket Cap106.05P/E (TTM)
138.500High132.470Low3.24MVolume132.790Open134.000Pre Close444.45MTurnover0.83%Turnover Ratio106.05P/E (Static)396.03MShares142.00052wk High26.40P/B53.80BFloat Cap74.75052wk Low--Dividend TTM390.22MShs Float164.863Historical High--Div YieldTTM4.50%Amplitude0.340Historical Low137.250Avg Price1Lot Size
About DexCom Company
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Company Profile
SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
MarketNASDAQ
Employees9600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200
Websitehttp://www.dexcom.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 15.44M
- Shelly Ramasamy Selvaraj
- Senior Vice President and Chief Information Officer
- --
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Girish Naganathan
- Executive Vice President and Chief Technology Officer
- 4.05M
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- --
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 4.43M
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 5.75M
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.54M
- Barry J. Regan
- Executive Vice President, Global Operations
- --
- Steven R. Pacelli
- Executive Vice President and Managing Director, Dexcom Ventures
- 2.92M
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Donald M. Abbey
- Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs
- --
- Paul R. Flynn
- Executive Vice President, Global Revenue
- --
- Rimma Driscoll
- Independent Director
- --
- Richard A. Collins
- Independent Director
- 317.05K
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 317.37K
- Mark G. Foletta
- Lead Independent Director
- 360.42K
- Karen M. Dahut
- Independent Director
- 317.05K
- Nicholas Augustinos
- Independent Director
- 319.30K
- Bridgette P. Heller
- Independent Director
- 317.37K
- Dr. Barbara E. Kahn
- Independent Director
- 319.30K
- Kyle Malady
- Independent Director
- 314.48K
- Steven R. Altman
- Independent Director
- 314.48K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
